# Camille and Henry Dreyfus Foundation Camille and Henry Dreyfus Foundation is an Endowment / Foundation based in New York, United States. ## Overview - **Organization type:** Endowment / Foundation - **Headquarters:** New York, United States - **Region:** North America - **Address:** 405 Lexington Avenue, Suite 909, New York, NY 10174, United States - **Founded:** 1946 - **Assets under management:** $100M–$500M (Altss estimate) - **Website:** dreyfus.org - **LinkedIn:** https://www.linkedin.com/company/camille-henry-dreyfus-foundation ## Regulatory record - **Reports private funds:** No ## About The Camille and Henry Dreyfus Foundation was established in 1946 by Camille Dreyfus, a Swiss chemist who co-founded the Celanese Corporation. After the death of his brother Henry in 1944, Camille dedicated a portion of his industrial fortune to create one of the few US foundations with a single-discipline mandate: to advance the chemical sciences. Governance remains tightly held within the Dreyfus family line through President H. Scott Walter and Secretary Mary Eileen Dowling Walter. The foundation’s capital, estimated at $104 million (Altss estimate), is deployed almost entirely through a programmatic grantmaking engine rather than direct venture or private equity investments. Its asset base includes publicly traded securities and corporate bonds, managed to sustain annual distributions for four signature programs. The Postdoctoral Program in Environmental Chemistry seeds early-stage academic labs. The Henry Dreyfus Teacher-Scholar Awards Program targets undergraduate-focused faculty. Its most visible asset is the Dreyfus Prize in the Chemical Sciences, a biennial $250,000 award that has recognized figures including MIT’s Robert Langer and Caltech’s Frances Arnold. The foundation also partners with the American Chemical Society (ACS) to administer national symposia and named lectureships. The foundation’s operational footprint is lean, run by Executive Director Scott Siegel out of a leased office at 405 Lexington Avenue in New York. The board blends family trustees—Henry C. Walter served as president from 2009 to 2020—with scientific advisors like Matthew V. Tirrell, dean of the University of Chicago’s Pritzker School of Molecular Engineering. While it does not operate adjacent investment vehicles, the foundation’s philanthropic capital is permanently wedded to its chartered mission: grantmaking in chemistry, not principal investment returns. In 2023, the foundation awarded a new round of Dreyfus Prize nominations, reinforcing its role as the discipline’s most concentrated private funder. Structurally, the Dreyfus Foundation sits in a rare class of asset owners: a single-mission science funder whose grantmaking produces measurable academic output—faculty hires, published research, and Nobel-caliber recognition—rather than portfolio exits. The prize committee draws from the ACS and the National Academy of Sciences, creating a sourcing network for talent discovery that looks more like fellowship curation than endowment management. That model, sustained across eight decades, has made the foundation’s financial underwriting the de facto subsidy for early-stage theoretical and environmental chemistry research in America. ## Sectors - Healthcare Services - Industrial Tech - Education ## People - H. Scott Walter — President of the Board - Scott Siegel — Executive Director - Mary Eileen Dowling Walter — Treasurer and Secretary - Milan Mrksich — Chair of the Scientific Affairs Committee and Board Member - Matthew V. Tirrell — Senior Scientific Advisor and Director - Paul Woitach — Vice President of the Foundation ## Questions ### Who runs investment decisions at the Camille and Henry Dreyfus Foundation? The foundation does not invest directly in companies or operate as a venture firm. Asset management oversight rests with the Board, currently led by President H. Scott Walter, with day-to-day financial management administered by Executive Director Scott Siegel. The portfolio consists primarily of publicly traded securities and corporate bonds, structured to fund annual grantmaking rather than generate principal growth. ### How does the foundation source its awardees and grant recipients? The foundation’s scientific leadership—including Senior Scientific Advisor Matthew V. Tirrell and the Scientific Affairs Committee chaired by Milan Mrksich—works in collaboration with the American Chemical Society and the National Academy of Sciences to identify candidates. Selection emphasizes early-career researchers and undergraduate-focused faculty, creating a structured talent pipeline rather than accepting unsolicited proposals for its major prizes. ### Does the Dreyfus Foundation take equity positions in biotech or materials science startups? No. Despite its alignment with the chemical sciences, the foundation is not an early-stage investor in commercial ventures. Its capital is used exclusively for charitable grants, awards, and educational programs. There is no record of the foundation making direct equity investments, co-investments alongside venture firms, or participating in limited partner commitments to funds. ### How is the Dreyfus Prize structured, and who has won it? The biennial Dreyfus Prize in the Chemical Sciences features a $250,000 monetary award and a citation, focused on a rotating theme within chemistry. Past recipients include Robert Langer (MIT), Frances Arnold (Caltech), and Peidong Yang (UC Berkeley)—each recognized for foundational contributions. The 2024 cycle is dedicated to Environmental Chemistry. The prize is the largest of its kind focused exclusively on a single disciplinary theme in chemistry. ## Related profiles - [RIOPRETOPREV](https://altss.com/profile/riopretoprev) - [Continental Grain Company](https://altss.com/profile/continental-grain-company) --- Last updated: 2026-06-03T20:00:00.000Z Canonical page: https://altss.com/profile/camille-and-henry-dreyfus-foundation-inc Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology